Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN113614075B enables efficient voriconazole intermediate synthesis. Reduces waste and enhances supply chain reliability for global pharmaceutical partners.
Patent CN1288145C reveals a novel Tiagabine synthesis avoiding organometallics. Discover cost-effective scaling and high-purity API intermediate supply strategies.
Advanced demethylation process for 4-deoxy daunorubicin intermediates. Reduces impurities and enhances scalability for reliable pharmaceutical intermediate supply chains.
Patent CN104030934B reveals high-purity Levocarnitine synthesis via Ru-BINAP catalyst. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply.
Patent CN104130187B details efficient asymmetric synthesis. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Novel catalytic sulfonation enables high-purity p-ethylbenzenesulfonamide production with reduced impurities and scalable manufacturing efficiency for pharmaceutical supply chains globally.
Patent CN104030934B reveals asymmetric hydrogenation for high-purity Levocarnitine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Discover a novel N-to-C synthesis route for Carfilzomib avoiding racemization. High yield, chromatography-free purification for cost-effective API manufacturing.
Patent CN105367434A details isobutyraldehyde route for pregabalin. Ensures high purity and supply chain stability for global pharmaceutical manufacturing needs.
Patent CN117586310A reveals a novel Ni-Al bimetallic catalyst for enantioselective C(sp3)-H activation, offering cost reduction in pharmaceutical intermediates manufacturing and high-purity chiral nitrogen-containing heterocycles.
Novel patent CN107778191A reveals optimized Iopromide synthesis. Reduces by-products, enhances purity, and ensures reliable supply chain for contrast media manufacturing.
Novel hydrolysis process for steroid intermediates ensures high yield and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN121270408A reveals a novel route for Elacestrant intermediates offering high purity and scalable production for reliable pharmaceutical intermediates supplier partnerships.
Novel Idelalisib preparation method offers significant cost reduction and enhanced supply chain reliability for global pharmaceutical manufacturing partners seeking high-purity APIs.
Advanced synthesis of 9-cis-retinoic acid analogs for CAD treatment via Pd-catalyzed coupling. Reliable pharma intermediate supplier offering scalable routes.
Novel patent CN105315212A enables efficient Tolvaptan production. Reduces steps, avoids heavy metals. Reliable supply chain partner for pharma intermediates.
Patent CN109305940B reveals a 3-step synthesis for Roxadustat intermediates. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN113336792A reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonates, offering superior stereoselectivity and yield for pharmaceutical manufacturing.
Efficient semi-synthesis of deserpidine from reserpine lactone via selective demethylation. Reduces costs and improves supply chain reliability for antihypertensive APIs.
Patent CN119874536A reveals high-purity MOCA purification. Achieve ≥99.0% purity and ≥90% yield for reliable polyurethane curing agent supply chains.